Which of the following analgesics should not be given in acute MI ?
**Core Concept**
The management of acute myocardial infarction (MI) involves careful consideration of analgesic options to balance pain relief with the potential for adverse effects on cardiac function. In this context, certain analgesics can exacerbate myocardial ischemia or worsen cardiac performance due to their pharmacological properties.
**Why the Correct Answer is Right**
Pentazocine is a mixed agonist-antagonist opioid that can increase sympathetic tone and heart rate, potentially exacerbating myocardial ischemia in the setting of an acute MI. Unlike morphine, which is a pure mu-opioid agonist that can provide effective analgesia while reducing sympathetic tone, pentazocine's action on kappa-opioid receptors can have the opposite effect. This makes pentazocine a less desirable choice for pain management in acute MI.
**Why Each Wrong Option is Incorrect**
**Option A:** Methadone is a long-acting opioid agonist that can be used for pain management in various settings, including acute MI. Its pharmacokinetic properties allow for effective analgesia with minimal risk of exacerbating myocardial ischemia.
**Option B:** Morphine is a pure mu-opioid agonist that is commonly used for pain relief in acute MI. Its ability to reduce sympathetic tone and provide effective analgesia makes it a preferred choice for this indication.
**Option C:** Buprenorphine is a partial mu-opioid agonist that can provide analgesia with a lower risk of respiratory depression compared to full opioid agonists. While it may not be the first choice for acute MI, it is not contraindicated in this setting.
**Clinical Pearl / High-Yield Fact**
In the context of acute MI, it is essential to choose analgesics that reduce sympathetic tone and provide effective pain relief without exacerbating myocardial ischemia. Morphine is a classic choice for this indication due to its ability to reduce anxiety, alleviate pain, and decrease myocardial oxygen demand.
**β Correct Answer: D. Pentazocine**